ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
Su M, Huang J, Li J, Qin X, Tang X, Jin F, Chen S, Jiang C, Zou Z, Peng K, Nuruzzaman M, Zhang J, Luo J, Liu S, Luo Z.
Su M, et al. Among authors: nuruzzaman m.
Oncotarget. 2016 Apr 5;7(14):19018-30. doi: 10.18632/oncotarget.7968.
Oncotarget. 2016.
PMID: 26967559
Free PMC article.